May 09, 2013

While drug companies celebrate price reductions that will allow girls in poor countries to be vaccinated against cervical cancer for $14 per patient, these prices are still out of reach for millions of people, MSF's Kate Elder explains.


View external media

Related News & Publications

Be part of MSF

Our supporters, donors and fundraisers are a vital part of the MSF movement.

Find out how you can support MSF's lifesaving work.

Learn more